PRDM5 and melanoma: Compared with the control group, the number of metastatic foci was significantly reduced in mice injected with PRDM5 knock‐down cells (Fig. 4B), suggesting that PRDM5 silencing impairs the metastatic potential of melanoma cells in vivo.